TDOC RSI Chart
Last 7 days
0.2%
Last 30 days
-14.9%
Last 90 days
-35.7%
Trailing 12 Months
-52.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 2.6B | 0 | 0 | 0 |
2023 | 2.5B | 2.5B | 2.6B | 2.6B |
2022 | 2.1B | 2.2B | 2.3B | 2.4B |
2021 | 1.4B | 1.6B | 1.9B | 2.0B |
2020 | 605.5M | 716.3M | 867.1M | 1.1B |
2019 | 456.8M | 492.6M | 519.6M | 553.3M |
2018 | 280.0M | 330.0M | 372.3M | 417.9M |
2017 | 139.2M | 157.3M | 193.5M | 233.3M |
2016 | 87.8M | 96.0M | 108.4M | 123.2M |
2015 | 50.6M | 58.6M | 67.7M | 77.4M |
2014 | 0 | 27.8M | 35.7M | 43.5M |
2013 | 0 | 0 | 0 | 19.9M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 17, 2024 | trencher daniel | sold | -13,210 | 13.21 | -1,000 | chief strategy officer |
Apr 02, 2024 | nanis nikolaos p. | sold | -6,598 | 14.314 | -461 | chief technology officer |
Apr 01, 2024 | nanis nikolaos p. | acquired | - | - | 1,232 | chief technology officer |
Mar 25, 2024 | geshuri arnnon | sold | -112,950 | 15.06 | -7,500 | chief people officer |
Mar 25, 2024 | geshuri arnnon | acquired | 20,475 | 2.73 | 7,500 | chief people officer |
Mar 18, 2024 | trencher daniel | sold | -15,180 | 15.18 | -1,000 | chief strategy officer |
Mar 05, 2024 | turitz andrew | sold | -82,050 | 14.53 | -5,647 | evp, corporate development |
Mar 04, 2024 | verstraete stephany | sold | -115,330 | 14.516 | -7,945 | chief marketing officer |
Mar 04, 2024 | napolitano richard j | sold | -54,652 | 14.516 | -3,765 | chief accounting officer |
Mar 04, 2024 | kornwasser laizer | sold | -266,354 | 14.516 | -18,349 | president, enterprise growth |
Which funds bought or sold TDOC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Center for Financial Planning, Inc. | unchanged | - | -323 | 755 | -% |
Apr 25, 2024 | Allworth Financial LP | reduced | -18.87 | -10,005 | 13,183 | -% |
Apr 25, 2024 | LECAP ASSET MANAGEMENT LTD | added | 78.79 | 386,684 | 1,916,280 | 0.40% |
Apr 25, 2024 | Bank of New York Mellon Corp | added | 4.85 | -4,913,700 | 13,608,400 | -% |
Apr 25, 2024 | Mendota Financial Group, LLC | unchanged | - | -148 | 348 | -% |
Apr 25, 2024 | Eudaimonia Partners, LLC | unchanged | - | -95,222 | 222,921 | 0.05% |
Apr 25, 2024 | nVerses Capital, LLC | new | - | 10,570 | 10,570 | 0.03% |
Apr 25, 2024 | Zurcher Kantonalbank (Zurich Cantonalbank) | added | 14.34 | -240,737 | 969,964 | -% |
Apr 25, 2024 | Lindbrook Capital, LLC | reduced | -79.84 | -9,550 | 1,570 | -% |
Apr 25, 2024 | Bogart Wealth, LLC | reduced | -6.82 | -988 | 1,857 | -% |
Unveiling Teladoc Health Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Teladoc Health Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 456.6B | 371.6B | 20.4 | 1.23 | ||||
CI | 103.6B | 195.3B | 19.29 | 0.53 | ||||
CVS | 84.5B | 357.8B | 10.12 | 0.24 | ||||
HCA | 81.1B | 65.0B | 15.47 | 1.25 | ||||
CNC | 39.7B | 155.5B | 14.51 | 0.26 | ||||
DVA | 11.7B | 12.1B | 16.93 | 0.96 | ||||
UHS | 11.5B | 14.3B | 16.01 | 0.8 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 31.02 | 3.73 | ||||
ACHC | 6.8B | 2.9B | -313.66 | 2.32 | ||||
AMN | 2.2B | 3.8B | 10.27 | 0.57 | ||||
AMEH | 2.0B | 1.4B | 33.48 | 1.47 | ||||
SMALL-CAP | ||||||||
ADUS | 1.5B | 1.1B | 24.52 | 1.45 | ||||
BKD | 1.3B | 3.0B | -6.97 | 0.44 | ||||
BEAT | 52.7M | - | -3.6 | - | ||||
AMS | 20.1M | 21.3M | 37.65 | 0.94 |
Teladoc Health Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -2.2% | 646,131,000 | 660,527,000 | 660,238,000 | 652,406,000 | 629,244,000 | 637,709,000 | 611,402,000 | 592,379,000 | 565,350,000 | 554,235,000 | 521,658,000 | 503,139,000 | 453,675,000 | 383,321,000 | 288,812,000 | 241,030,000 | 180,799,000 | 156,489,000 | 137,969,000 | 130,276,000 | 128,573,000 |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 83,896,000 |
Costs and Expenses | 5.4% | 733,253,000 | 695,608,000 | 724,963,000 | 724,051,000 | 706,346,000 | 4,453,262,000 | 683,132,000 | 3,688,931,000 | 7,234,729,000 | 595,664,000 | 582,234,000 | 582,087,000 | 538,353,000 | 841,827,000 | 308,537,000 | 248,209,000 | 201,810,000 | 172,077,000 | 157,913,000 | 152,299,000 | 151,460,000 |
S&GA Expenses | 1.7% | 54,364,000 | 53,451,000 | 52,309,000 | 53,530,000 | 54,490,000 | 56,279,000 | 54,634,000 | 57,930,000 | 58,329,000 | 59,330,000 | 62,602,000 | 63,856,000 | 64,793,000 | 93,942,000 | 23,483,000 | 18,687,000 | 17,940,000 | 16,751,000 | 16,120,000 | 15,832,000 | 16,212,000 |
R&D Expenses | -9.5% | 81,388,000 | 89,938,000 | 84,289,000 | 87,309,000 | 86,985,000 | 82,931,000 | 84,590,000 | 78,696,000 | 87,412,000 | 72,867,000 | 80,250,000 | 80,759,000 | 78,008,000 | 92,697,000 | 29,958,000 | 23,029,000 | 19,257,000 | 16,246,000 | 15,746,000 | 16,665,000 | 15,987,000 |
EBITDA Margin | -3.7% | -0.08 | -0.08 | -1.42 | -1.47 | -2.74 | -5.56 | -4.10 | -4.29 | -3.09 | -0.05 | -0.37 | -0.42 | -0.46 | - | - | - | - | - | - | - | - |
Interest Expenses | -11.0% | 5,649,000 | 6,345,500 | 5,646,000 | 5,835,000 | 3,648,000 | 10,151,000 | 6,149,000 | 5,562,000 | -5,480,000 | 142,634,000 | -18,895,000 | -20,473,000 | -22,125,000 | -21,100,500 | -16,970,000 | -13,262,000 | -8,618,000 | -7,581,000 | -7,700,000 | -7,211,000 | -6,521,000 |
Income Taxes | -23.2% | 2,700,000 | 3,515,000 | -2,484,000 | -952,000 | 681,000 | -1,841,000 | -1,171,000 | -1,188,000 | 388,000 | -49,721,500 | 3,643,000 | 3,196,000 | 87,000,000 | -85,457,000 | -2,300,000 | -2,400,000 | -700,000 | -4,125,000 | -7,300,000 | 100,000 | 742,000 |
Earnings Before Taxes | -212.1% | -79,199,000 | -25,375,000 | -59,557,000 | -66,129,000 | -68,547,000 | -3,811,912,000 | -74,647,000 | -3,102,649,000 | -6,674,135,000 | -60,726,000 | -80,697,000 | -130,623,000 | -112,610,000 | -479,424,000 | -38,174,000 | -28,081,000 | -30,314,000 | -23,169,000 | -27,644,000 | -29,234,000 | -29,408,000 |
EBT Margin | -4.2% | -0.09 | -0.08 | -1.55 | -1.59 | -2.86 | -5.68 | -4.27 | -4.44 | -3.24 | -0.19 | -0.43 | -0.47 | -0.48 | - | - | - | - | - | - | - | - |
Net Income | -183.5% | -81,889,000 | -28,890,000 | -57,073,000 | -65,177,000 | -69,228,000 | -3,810,071,000 | -73,476,000 | -3,101,461,000 | -6,674,523,000 | -10,985,000 | -84,340,000 | -133,819,000 | -199,649,000 | -393,967,000 | -35,884,000 | -25,682,000 | -29,603,000 | -19,044,000 | -20,346,000 | -29,324,000 | -30,150,000 |
Net Income Margin | -5.1% | -0.09 | -0.08 | -1.55 | -1.59 | -2.86 | -5.68 | -4.24 | -4.42 | -3.22 | -0.21 | -0.44 | -0.47 | -0.48 | - | - | - | - | - | - | - | - |
Free Cashflow | -94.0% | 7,771,000 | 128,678,000 | 99,808,000 | 99,278,000 | 10,793,000 | 59,354,000 | 59,191,000 | 89,927,000 | -35,660,000 | 80,285,000 | 75,385,000 | 49,927,000 | -20,141,000 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -1.6% | 4,321 | 4,392 | 4,328 | 4,316 | 4,309 | 4,345 | 8,104 | 8,103 | 11,092 | 17,735 | 17,653 | 17,611 | 17,582 | 17,755 | 3,449 | 2,419 | 1,603 | 1,603 | 1,568 | 1,565 | 1,552 |
Current Assets | -0.2% | 1,486 | 1,489 | 1,387 | 1,321 | 1,287 | 1,315 | 1,288 | 1,257 | 1,208 | 1,225 | 1,157 | 1,105 | 1,032 | 1,060 | 1,310 | 1,403 | 596 | 588 | 558 | 533 | 541 |
Cash Equivalents | -2.3% | 1,098 | 1,124 | 1,031 | 959 | 889 | 918 | 900 | 881 | 836 | 893 | 824 | 784 | 720 | 733 | 1,187 | 1,309 | 508 | 514 | 475 | 440 | 434 |
Inventory | 9.3% | 32.00 | 30.00 | 36.00 | 34.00 | 46.00 | 56.00 | 59.00 | 60.00 | 71.00 | 73.00 | 57.00 | 57.00 | 58.00 | 56.00 | 12.00 | - | - | - | - | - | - |
Net PPE | -7.7% | 30.00 | 32.00 | 33.00 | 30.00 | 30.00 | 30.00 | 27.00 | 27.00 | 28.00 | 27.00 | 27.00 | 28.00 | 28.00 | 29.00 | 20.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Goodwill | 0% | 1,073 | 1,073 | 1,073 | 1,073 | 1,073 | 1,073 | 4,846 | 4,858 | 7,900 | 14,504 | 14,470 | 14,455 | 14,452 | 14,581 | 1,691 | 900 | 734 | 746 | 738 | 748 | 734 |
Current Liabilities | -7.6% | 389 | 421 | 403 | 383 | 381 | 400 | 411 | 371 | 307 | 331 | 302 | 276 | 260 | 333 | 201 | 124 | 97.00 | 90.00 | 85.00 | 70.00 | 72.00 |
Long Term Debt | 0.1% | 1,540 | 1,539 | 1,538 | 1,537 | 1,536 | 1,535 | 1,534 | 1,534 | 1,533 | 1,226 | 1,211 | 1,201 | 1,353 | 1,380 | 953 | 948 | 447 | 440 | 434 | 427 | 421 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.00 | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 1,539 | 1,538 | 1,537 | 1,536 | 1,535 | 1,534 | 1,534 | 1,533 | 1,226 | 1,211 | 1,201 | 1,353 | 1,380 | 953 | 948 | 447 | 440 | 434 | 427 | 421 |
Shareholder's Equity | -1.6% | 2,289 | 2,326 | 2,294 | 2,295 | 2,291 | 2,308 | 6,053 | 6,085 | 9,143 | 16,046 | 15,988 | 16,001 | 15,829 | 15,884 | 2,231 | 1,295 | 1,000 | 1,014 | 994 | 1,003 | 1,002 |
Retained Earnings | -0.5% | -15,310 | -15,228 | -15,199 | -15,142 | -15,077 | -15,008 | -11,198 | -11,124 | -8,023 | -1,421 | -1,410 | -1,326 | -1,192 | -992 | -598 | -562 | -537 | -507 | -488 | -468 | -438 |
Additional Paid-In Capital | 0.3% | 17,638 | 17,592 | 17,535 | 17,476 | 17,410 | 17,359 | 17,300 | 17,239 | 17,177 | 17,473 | 17,399 | 17,315 | 17,017 | 16,858 | 2,835 | 1,880 | 1,572 | 1,539 | 1,510 | 1,483 | 1,457 |
Shares Outstanding | 1.6% | 169 | 167 | 166 | 165 | 164 | 163 | 161 | 161 | 161 | 157 | 156 | 154 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 4,145 | - | - | - | 5,334 | - | - | - | 26,317 | - | - | - | 14,937 | - | - | - | 4,607 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -93.1% | 8,920 | 130,082 | 105,601 | 101,182 | 13,156 | 65,549 | 63,021 | 92,469 | -31,747 | 83,208 | 76,591 | 52,217 | -18,026 | -114,936 | 32,195 | 35,550 | -6,320 | 18,122 | 13,490 | 6,149 | -7,892 |
Share Based Compensation | -9.6% | 42,325 | 46,823 | 52,964 | 55,725 | 46,038 | 50,754 | 55,662 | 51,000 | 60,436 | 61,615 | 71,701 | 82,970 | 86,300 | 414,380 | 20,908 | 21,928 | 18,315 | 18,457 | 17,354 | 17,368 | 13,523 |
Cashflow From Investing | 2.7% | -35,512 | -36,506 | -37,647 | -36,570 | -45,624 | -53,891 | -41,448 | -44,837 | -27,567 | -20,075 | -34,708 | -2,168 | -16,030 | -413,925 | -155,460 | -9,662 | -11,928 | 9,547 | 13,194 | -5,064 | 7,336 |
Cashflow From Financing | 198.6% | 1,751 | -1,775 | 5,068 | 4,208 | 3,353 | 4,381 | 634 | -1,334 | 2,816 | 6,625 | 784 | 11,363 | 22,175 | 70,436 | 422 | 773,225 | 15,053 | 10,041 | 9,153 | 5,198 | 10,702 |
Consolidated Statements of Operations and Other Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Revenue | $ 2,602,415 | $ 2,406,840 | $ 2,032,707 |
Expenses: | |||
Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 760,031 | 743,987 | 650,258 |
Operating expenses: | |||
Advertising and marketing | 688,854 | 623,536 | 416,726 |
Sales | 213,780 | 227,172 | 250,581 |
Technology and development | 348,521 | 333,629 | 311,884 |
General and administrative | 464,659 | 449,855 | 438,007 |
Acquisition, integration, and transformation costs | 21,110 | 15,620 | 26,643 |
Restructuring costs | 16,942 | 7,416 | 0 |
Depreciation | 11,138 | 11,407 | 8,941 |
Amortization | 325,933 | 244,620 | 195,298 |
Goodwill impairment | 0 | 13,402,812 | 0 |
Total expenses | 2,850,968 | 16,060,054 | 2,298,338 |
Loss from operations | (248,553) | (13,653,214) | (265,631) |
Loss on extinguishment of debt | 0 | 0 | 43,748 |
Interest income | (46,782) | (12,674) | (776) |
Interest expense | 22,282 | 21,944 | 81,141 |
Other (income) expense, net | (4,445) | 859 | (5,088) |
Loss before provision for income taxes | (219,608) | (13,663,343) | (384,656) |
Provision for income taxes | 760 | (3,812) | 44,137 |
Net loss | (220,368) | (13,659,531) | (428,793) |
Other comprehensive income (loss), net of tax: | |||
Currency translation adjustment and other | 5,786 | (36,491) | (24,803) |
Comprehensive loss | $ (214,582) | $ (13,696,022) | $ (453,596) |
Net loss per share, basic (in dollars per share) | $ (1.34) | $ (84.60) | $ (2.73) |
Net loss per share, diluted (in dollars per share) | $ (1.34) | $ (84.60) | $ (2.73) |
Weighted-average shares used to compute basic net loss per share (in shares) | 164,578,219 | 161,457,123 | 156,939,349 |
Weighted-average shares used to compute diluted net loss per share (in shares) | 164,578,219 | 161,457,123 | 156,939,349 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,123,675 | $ 918,182 |
Accounts receivable, net of allowance for doubtful accounts of $4,240 and $4,324 at December 31, 2023 and December 31, 2022, respectively | 217,423 | 210,554 |
Inventories | 29,513 | 56,342 |
Prepaid expenses and other current assets | 118,437 | 130,310 |
Total current assets | 1,489,048 | 1,315,388 |
Property and equipment, net | 32,032 | 29,641 |
Goodwill | 1,073,190 | 1,073,190 |
Intangible assets, net | 1,677,781 | 1,836,765 |
Operating lease - right-of-use assets | 40,060 | 41,831 |
Other assets | 80,258 | 48,540 |
Total assets | 4,392,369 | 4,345,355 |
Current liabilities: | ||
Accounts payable | 43,637 | 47,690 |
Accrued expenses and other current liabilities | 178,634 | 168,693 |
Accrued compensation | 102,686 | 81,554 |
Deferred revenue-current | 95,659 | 101,832 |
Total current liabilities | 420,616 | 399,769 |
Other liabilities | 1,080 | 1,618 |
Operating lease liabilities, net of current portion | 42,837 | 38,042 |
Deferred revenue, net of current portion | 13,623 | 11,954 |
Deferred taxes, net | 49,452 | 50,939 |
Convertible senior notes, net | 1,538,688 | 1,535,288 |
Commitments and contingencies (Note 17) | ||
Stockholders’ equity: | ||
Common stock, $0.001 par value; 300,000,000 shares authorized; 166,658,253 shares and 162,840,360 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 167 | 163 |
Additional paid-in capital | 17,591,551 | 17,358,645 |
Accumulated deficit | (15,228,655) | (15,008,287) |
Accumulated other comprehensive loss | (36,990) | (42,776) |
Total stockholders’ equity | 2,326,073 | 2,307,745 |
Total liabilities and stockholders’ equity | $ 4,392,369 | $ 4,345,355 |